Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

NRx Pharmaceuticals, Inc. (NRXPW)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.1272-0.0034 (-2.60%)
At close: 03:15PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/30/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.72
52-Week Change 3N/A
S&P500 52-Week Change 3-11.60%
52 Week High 30.1895
52 Week Low 30.1272
50-Day Moving Average 3N/A
200-Day Moving Average 3N/A

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 5N/A
Implied Shares Outstanding 6N/A
Float 841.98M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-231.52%
Return on Equity (ttm)-425.62%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -105.89M
Net Income Avi to Common (ttm)-336.84M
Diluted EPS (ttm)-6.2470
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)40.2M
Total Cash Per Share (mrq)0.6
Total Debt (mrq)520k
Total Debt/Equity (mrq)1.64
Current Ratio (mrq)3.66
Book Value Per Share (mrq)0.48

Cash Flow Statement

Operating Cash Flow (ttm)-45.07M
Levered Free Cash Flow (ttm)-55.66M
Advertisement
Advertisement